Subscribe To

Price Alert Latest News Economic Calendar News

JAGX / Here's Why Jaguar Health Shares Are Popping Off

Jaguar Health Inc (NASDAQ: JAGX) shares are trading higher by 31.2% at $0.70 after the company announced an agreement granting Quadri Pharmaceuticals for exclusive promotional, commercialization and distribution rights for specified human indications of crofelemer in the Middle East. Per. Read More

Demo Live Account See Partner Details

Content Topics

Here

Jaguar

Health

Popping

Here s

Stock

JAGX

Posted: Mar 31 2022, 16:11

Author Name: Benzinga

JAGX News

By Accesswire
October 12, 2023

Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum

Top line results expected in the coming weeks for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related

By Seeking Alpha
August 14, 2023

Jaguar Health, Inc. (JAGX) Q2 2023 Earnings Call Transcript

Jaguar Health, Inc. (NASDAQ:JAGX ) Q2 2023 Earnings Conference Call August 14, 2023 8:30 AM ET Company Participants Lisa Conte - President and Chief E

By Accesswire
August 3, 2023

Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC

SAN FRANCISCO, CA / ACCESSWIRE / August 3, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president

By Accesswire
June 15, 2023

Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference

Reminder: Ladenburg Thalmann to host virtual discussion June 22, 2023 at 1:00 PM EDT with Jaguar CEO and leading patient advocates on impact of cancer

By Zacks Investment Research
June 13, 2023

Jaguar Animal Health, Inc. (JAGX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Jaguar Animal Health, Inc. (JAGX), indicating that the stock has found supp

By Seeking Alpha
March 27, 2023

Jaguar Health, Inc. (JAGX) Q4 2022 Earnings Call Transcript

Jaguar Health, Inc. (NASDAQ:JAGX ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Lisa Conte - President & Chief Exec

By Accesswire
March 24, 2023

Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT

Click here to register for webcast Company plans to file its Annual Report on March 24, 2023 on Form 10-K for the fiscal year ended December 31, 2022

By InvestorPlace
January 23, 2023

Is Jaguar Health (JAGX) Stock Really Up 6,800%?

Jaguar Health (NASDAQ: JAGX ) stock is on the move Monday as investors seek answers to its massive 6,800% gain this morning. For the record, JAGX stoc

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.